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Abstract
Context—Review of routinely collected tuberculosis genotyping results following a known 
outbreak is a potential mechanism to examine the effectiveness of outbreak control measures.




Participants—All tuberculosis cases identified as a result of ≥5-person outbreaks investigated 
by the Centers for Disease Control and Prevention during 2003–2007 (original outbreak cases), 
and subsequent culture-positive TB cases with matching M. tuberculosis genotypes reported in the 
same county during 2004–2008 (post-outbreak cases).
Main Outcome Measure—Proportion of demographic, social, and clinical characteristics of 
tuberculosis outbreak cases compared to post-outbreak cases. Secondary: Proportion of 
demographic, social, and clinical characteristics of epidemiologically linked versus nonlinked 
cases.
Results—Six outbreaks with 111 outbreak cases and 110 post-outbreak cases were identified. 
Differences between outbreak and post-outbreak cases were gender (69% male versus 85%; 
p<0.01), birth origin (3% foreign-born versus 11% ; p=0.02), disease severity (48% sputum smear-
positive versus 62%; p=0.04), homelessness (38% versus 51%; p=0.05), and injection drug use 
(4% versus 11%; p=0.04). For five of the six outbreaks, the status of epidemiologic relationships 
among post-outbreak cases was available (n=89). The post-outbreak cases with a known 
epidemiologic link to the original outbreak were in younger persons (age 39 versus 47; p<0.01), 
and a larger proportion reported injection drug use (18% versus 4%; p=0.04) or noninjection drug 
use (44% versus 18%; p<0.01) than those without a reported link.
Conclusions—Health jurisdictions can utilize genotyping data to monitor and define the 
characteristics of post-outbreak cases related to the original outbreak.
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The causative agent of tuberculosis (TB), Mycobacterium tuberculosis, is spread through the 
air from person to person. M. tuberculosis genotyping has been used for more than a decade 
to study the epidemiology of TB, identify and monitor TB outbreaks, and describe risk 
factors associated with transmission.1–5 Genotyping can help distinguish TB cases involved 
in the same chain of disease transmission by confirming suspected relationships and 
identifying potential new ones.
Approximately 80% of reported TB cases in the United States each year are diagnosed via 
microbial culture (culture positive); only culture-positive cases can be genotyped.6 With the 
Centers for Disease Control and Prevention (CDC)’s establishment of the National 
Tuberculosis Genotyping Service (NTGS) in 2004, TB genotyping for each culture-positive 
TB case in the United States is available at no cost to patients, healthcare providers, or 
health departments.7 Results are available to the TB control program that submits the case’s 
M. tuberculosis isolate and to the state health department of that jurisdiction. For the initial 
2004–2007 NTGS period, genotyping results were available for approximately 66% of all 
culture-positive TB cases in the United States.8 By 2009, that percentage was approximately 
81%; the goal is to achieve universal genotyping (100%).
Beginning in 2010, state and local TB control programs gained access to their genotyping 
results via a secure online platform, the TB Genotyping Information Management System 
(TB GIMS), where each case with NTGS results is linked with its corresponding National 
Tuberculosis Surveillance System (NTSS) case report.6,8,9 TB GIMS has the potential to 
provide near real-time epidemiologic data to TB control programs, which can use this 
information to improve TB control by examining the effectiveness of interventions, such as 
case treatment and contact investigation, to halt chains of transmission.9
As one approach to identify additional outbreak-related cases after experiencing an 
outbreak, TB control programs can monitor genotyping results in their jurisdiction to see if 
the outbreak genotype recurs. Such a review of routine TB genotyping results is a potential 
mechanism to examine the effectiveness of outbreak control measures. To examine how 
genotyping information might enhance post-outbreak monitoring, our study compared 
characteristics of TB cases identified during known outbreaks to later cases with matching 
TB genotypes.
DESIGN
Participants, definitions, and data collection
Included in this analysis were case data from TB outbreaks investigated by CDC through 
onsite assistance during 2003–2007 where there were ≥5 cases with matching TB genotypes 
in a single U.S. county. Genotyping results were provided by the NTGS, which uses 
standard molecular characterization methods.10 A matching genotype was defined as 
identical spoligotype and 12-locus mycobacterial interspersed repetitive unit variable 
number tandem repeats (MIRU-VNTR) results between cases.
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The beginning of the outbreak was defined by the health jurisdiction seeking assistance, as 
reported in the letter of invitation to CDC. For the purposes of this analysis, the end of each 
outbreak was defined as the conclusion of CDC onsite assistance, which coincided with the 
end of the most intensive part of the investigation.
Within each CDC investigation, an outbreak case was defined as either having a matching 
genotype to, or, in the absence of genotype results (e.g., clinically diagnosed, culture-
negative case), an epidemiologic link with, another outbreak case. An epidemiologic link 
was defined as being in the same location at the same time, as verified by record review or 
personal communication. In addition, outbreak cases were required to occur between the 
beginning and the end of the outbreak as defined above. Non-outbreak cases were all other 
TB cases reported by that county during the outbreak period.
A post-outbreak case was any TB case that occurred subsequent to the end of the outbreak 
(as defined above) in the same county where the outbreak occurred whose genotype matched 
the outbreak genotype. For this analysis, the post-outbreak investigation period 
encompassed 2004–2008, thus ranging from 1 to 5 years after each outbreak investigation. 
For post-outbreak cases, we attempted to ascertain epidemiologic relationships to the 
original outbreak through follow-up discussions with local and state TB control programs in 
those jurisdictions.
Demographic, social, and clinical characteristics for all cases were abstracted from NTSS 
records maintained at CDC. The month and year that health jurisdictions counted cases for 
surveillance purposes was used as a proxy for diagnosis date, which is not captured in the 
NTSS.
Statistical analysis and outcome measures
The NTSS provided an enumeration of all TB cases reported in each county during the 
defined outbreak period. Chi-square tests were used to determine whether outbreak cases 
were more likely than non-outbreak cases to have M. tuberculosis isolates submitted for 
genotyping. We then compared characteristics of outbreak to post-outbreak cases, and, 
among post-outbreak cases, compared the epidemiologically linked with the nonlinked 
cases. Fisher’s exact tests were used when cell sizes for any variable were 5 or fewer. 
Wilcoxon nonparametric tests and t-tests were performed to determine whether the 
distributions of median or mean age differed between outbreak and post-outbreak cases. A 
2-way contingency table analysis tool available at http://statpages.org/ctab2×2.html and SAS 
version 9.1.3 (SAS Institute) were used to perform analyses. A p-value of <=0.05 was 
considered significant.
RESULTS
Six outbreaks investigated by CDC during the study period met our inclusion criteria. In the 
six affected counties, 81% of all outbreak cases had isolates submitted for genotyping versus 
66% of non-outbreak cases (p=0.01).
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Outbreak versus post-outbreak cases
We identified a total of 111 outbreak cases and 110 post-outbreak cases. For post-outbreak 
cases, the mean time from the defined end of the outbreak to the month it was counted by 
the health jurisdiction as a new TB case was 23 months (Standard deviation = 14 months). 
Blacks represented the highest proportion of cases (65%), with no significant difference 
between outbreak and post-outbreak cases (Table). Forty-eight percent (48%) of outbreak 
cases, compared with 62% of post-outbreak, had acid-fast bacilli (AFB) sputum smear-
positive disease (p=0.04). More of the post-outbreak cases were in males (69% of outbreak 
cases versus 85% post-outbreak, p<0.01), or in persons who reported injection drug use (4% 
versus 11%, p=0.04) or had a history of homelessness (38% versus 51%, p=0.05) within the 
past year, or were foreign-born (3% versus 11%, p=0.02). All foreign-born cases were in 
persons who had resided in the United States for ≥2 years at time of diagnosis.
Epidemiologically linked versus nonlinked post-outbreak cases
Information on epidemiologic links for post-outbreak cases was available for five of the six 
outbreaks. These five outbreaks encompassed 89 post-outbreak cases: 39 epidemiologically 
linked and 50 not able to be linked to the original outbreak (i.e., nonlinked). The mean time 
from outbreak investigation to diagnostic verification did not differ between 
epidemiologically linked and nonlinked cases (24 versus 25 months, p=0.80). A high 
proportion of post-outbreak cases epidemiologically linked to the initial outbreak were in 
black males aged 25–44 years (66%), or in persons who were homeless (51%) or who self-
reported excess alcohol use within the past year (49%). Seventy-two percent (72%) of 
epidemiologically linked cases had AFB sputum smear-positive disease versus 60% of 
nonlinked cases (p=0.25), and the majority of both groups had pulmonary TB (87% versus 
78%, p=0.26). Among the nonlinked, a high proportion were black (60%), male (90%), or 
had a history of homelessness (42%) or excess alcohol use (54%) within the prior year. A 
difference between epidemiologically linked and nonlinked was observed in mean age (39 
and 47 respectively, p<0.01, standard deviation for both groups 11.2). Additionally, 
epidemiologically linked cases were significantly more likely than nonlinked cases to have 
reported a history of injection drug use (18% versus 4%, p=0.04), and noninjection drug use 
(44% versus 18%, p<0.01) within the past year.
CONCLUSION
The utility of genotyping during outbreak investigation is well established, and the results of 
our study suggest that genotyping remains an important tool after outbreak investigations. In 
general, TB outbreak cases in this study had similar characteristics to post-outbreak cases 
diagnosed up to 4 years later. This similarity suggests that newly diagnosed TB cases with a 
matching genotype subsequent to an outbreak and in the same area are associated with that 
outbreak and therefore warrant further investigation.
The higher proportion of outbreak cases than non-outbreak cases with genotyping results is a 
result potentially driven by the utility of genotyping during an outbreak investigation to 
confirm relationships among culture-confirmed TB cases with suspected epidemiologic 
links. There were other limitations of this analysis. As CDC assistance is often requested for 
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complex investigations, the outbreaks presented here are not necessarily representative of 
outbreaks routinely investigated by state and local TB control programs. Other limitations 
included the limited time for follow-up of post-outbreak cases for the 2006–2007 outbreaks, 
the potential ecological issues associated with aggregating data from different geographic 
areas, and the potential under-representation of epidemiologically linked cases diagnosed in 
neighboring counties.
Of those characteristics with a significant difference, the proportion sputum smear-positive 
were likely higher in the post-outbreak group because all cases in that group were culture-
positive, while the outbreak group included cases diagnosed by clinical criteria such as 
positive tuberculin skin test and abnormal chest radiograph in the absence of positive culture 
for M. tuberculosis.6
TB outbreak investigations are resource-intensive and time-consuming, and monitoring the 
effectiveness of control measures is critical. New tools such as TB GIMS have the potential 
to facilitate post-outbreak TB disease monitoring by making genotyping results readily 
available to state and local health jurisdictions within a relatively short period of time.
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